Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
Ronen Sadeh, Israa Sharkia, Gavriel Fialkoff, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 5, pp. 586-598
Open Access | Times Cited: 109

Showing 26-50 of 109 citing articles:

Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures
Angela Oberhofer, Abel J. Bronkhorst, Carsten Uhlig, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1834-1834
Open Access | Times Cited: 33
Using all our genomes: Blood‐based liquid biopsies for the early detection of cancer
Eddie Adams, Gregory D. Sepich‐Poore, Sandrine Miller‐Montgomery, et al.
View (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 32
Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus
Yang Yang, Ying Luan, Feng Qi, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 30
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA
Mingyun Bae, Gyuhee Kim, Tae-Rim Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood
Yuhuan Tao, Shaozhen Xing, Shuai Zuo, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101281-101281
Open Access | Times Cited: 16
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair
Cameron Herberts, Alexander W. Wyatt, Paul L. Nguyen, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 14
Circulating nucleosomes as potential biomarkers for cancer diagnosis and treatment monitoring
Huawei Wang, Yin Wang, Dejiu Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 130005-130005
Closed Access | Times Cited: 5
Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?
Daniel Stetson, Paul Labrousse, Hugh Russell, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 23, pp. 2736-2740
Closed Access | Times Cited: 5
Cell-free DNA technologies for the analysis of brain cancer
Richard Mair, Florent Moulière
British Journal of Cancer (2021) Vol. 126, Iss. 3, pp. 371-378
Open Access | Times Cited: 37
Epigenetics of Hepatic Insulin Resistance
Hannah Maude, Claudia Sanchez-Cabanillas, Inês Cebola
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 31
Combinatorial Power of cfDNA, CTCs and EVs in Oncology
Corinna Keup, Rainer Kimmig, Sabine Kasimir‐Bauer
Diagnostics (2022) Vol. 12, Iss. 4, pp. 870-870
Open Access | Times Cited: 22
Exhaustive identification of genome-wide binding events of transcriptional regulators
Anna Nordin, Pierfrancesco Pagella, Gianluca Zambanini, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 7, pp. e40-e40
Open Access | Times Cited: 3
Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis
Christa Caggiano, Marco Morselli, Xia Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNA
Xu Hua, Hui Zhou, Hui‐Chen Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
Megan E. Barefoot, Netanel Loyfer, Amber J. Kiliti, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 29
Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer
Arlou Kristina Angeles, Florian Janke, Simone Bauer, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5615-5615
Open Access | Times Cited: 27
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension
Samuel B. Brusca, Jason M. Elinoff, Yvette Zou, et al.
Circulation (2022) Vol. 146, Iss. 14, pp. 1033-1045
Open Access | Times Cited: 19
Cell-free DNA in lung transplantation: research tool or clinical workhorse?
Michael Keller, Sean Agbor-Enoh
Current Opinion in Organ Transplantation (2022) Vol. 27, Iss. 3, pp. 177-183
Open Access | Times Cited: 18
Megakaryocyte- and erythroblast-specific cell-free DNA patterns in plasma and platelets reflect thrombopoiesis and erythropoiesis levels
Joshua Moss, Roni Ben‐Ami, Ela Shai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
Jodie Wong, Rohit Muralidhar, Liang Wang, et al.
Biomedical Journal (2024), pp. 100718-100718
Open Access | Times Cited: 3
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling
Talal El Zarif, Catherine B. Meador, Xintao Qiu, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3798-3811
Open Access | Times Cited: 3
Plasmacytoid dendritic cells control homeostasis of megakaryopoiesis
Florian Gaertner, Hellen Ishikawa‐Ankerhold, Susanne Stutte, et al.
Nature (2024) Vol. 631, Iss. 8021, pp. 645-653
Open Access | Times Cited: 3
Epigenetic liquid biopsies: a novel putative biomarker in immunology and inflammation
Ilana Fox-Fisher, Ruth Shemer, Yuval Dor
Trends in Immunology (2023) Vol. 44, Iss. 5, pp. 356-364
Closed Access | Times Cited: 9
Liquid biopsies for cancer: From bench to clinic
Zhenhui Chen, Chenghao Li, Yue Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 8
Artificial intelligence in biology and medicine, and radioprotection research: perspectives from Jerusalem
Yehoshua Socol, Ariella Richardson, Imene Garali-Zineddine, et al.
Frontiers in Artificial Intelligence (2024) Vol. 6
Open Access | Times Cited: 2

Scroll to top